BioVie Inc. Labor and Related Expense
BioVie Inc. (BIVI) reported Labor and Related Expense of $70.69 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LaborAndRelatedExpense · last filed 2018-11-14
- BioVie Inc. labor and related expense for the quarter ending 2018-09-30 was $70.69K, a 0.92% decline year-over-year.
- BioVie Inc. labor and related expense for the quarter ending 2018-06-30 was $107.58K, a 50.78% increase year-over-year.
- BioVie Inc. labor and related expense for the quarter ending 2018-03-31 was $61.25K, a 14.16% decline year-over-year.
- BioVie Inc. labor and related expense for the quarter ending 2017-12-31 was $71.35K, a 0.00% change year-over-year.
- BioVie Inc. labor and related expense for fiscal 2018 was $311.52K, a 9.16% increase from fiscal 2017.
- BioVie Inc. labor and related expense for fiscal 2017 was $285.39K, a 54.65% increase from fiscal 2016.
- BioVie Inc. labor and related expense for fiscal 2016 was $184.54K, a 13.96% increase from fiscal 2015.
- BioVie Inc. labor and related expense for fiscal 2015 was $161.93K, a 0.28% increase from fiscal 2014.
| Period end | Labor and Related Expense 3 month | Labor and Related Expense 6 month | Labor and Related Expense 9 month | Labor and Related Expense 12 month |
|---|---|---|---|---|
| 2018-09-30 | $70.69K 10-Q · filed 2018-11-14 | $178.28K derived: sum of 2 quarters · filed 2018-11-14 | $239.52K derived: sum of 3 quarters · filed 2018-11-14 | $310.87K derived: sum of 4 quarters · filed 2018-11-14 |
| 2018-06-30 | $107.58K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-05 | $168.83K derived: sum of 2 quarters · filed 2018-10-05 | $240.18K derived: sum of 3 quarters · filed 2018-10-05 | $311.52K 10-K · filed 2018-10-05 |
| 2018-03-31 | $61.25K 10-Q · filed 2018-05-14 | $132.59K derived: sum of 2 quarters · filed 2018-05-14 | $203.94K 10-Q · filed 2018-05-14 | $275.29K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-12-31 | $71.35K 10-Q · filed 2018-02-14 | $142.70K 10-Q · filed 2018-02-14 | $214.04K derived: sum of 3 quarters · filed 2018-11-14 | $285.39K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-09-30 | $71.35K 10-Q · filed 2018-11-14 | $142.70K derived: sum of 2 quarters · filed 2018-11-14 | $214.04K derived: sum of 3 quarters · filed 2018-11-14 | $285.39K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $71.35K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-05 | $142.70K derived: sum of 2 quarters · filed 2018-10-05 | $214.04K derived: sum of 3 quarters · filed 2018-10-05 | $285.39K 10-K · filed 2018-10-05 |
| 2017-03-31 | $71.35K 10-Q · filed 2018-05-14 | $142.70K derived: sum of 2 quarters · filed 2018-05-14 | $214.04K 10-Q · filed 2018-05-14 | $277.47K derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $71.35K 10-Q · filed 2018-02-14 | $142.70K 10-Q · filed 2018-02-14 | $206.13K derived: sum of 3 quarters · filed 2018-02-14 | $246.50K derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-09-30 | $71.35K 10-Q · filed 2017-11-08 | $134.78K derived: sum of 2 quarters · filed 2017-11-08 | $175.15K derived: sum of 3 quarters · filed 2017-11-08 | $215.52K derived: sum of 4 quarters · filed 2017-11-08 |
| 2016-06-30 | $63.43K derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-24 | $103.80K derived: sum of 2 quarters · filed 2017-08-24 | $144.17K derived: sum of 3 quarters · filed 2017-08-24 | $184.54K 10-K · filed 2017-08-24 |
| 2016-03-31 | $40.37K 10-Q · filed 2017-05-09 | $80.74K derived: sum of 2 quarters · filed 2017-05-09 | $121.11K 10-Q · filed 2017-05-09 | $161.48K derived: sum of 4 quarters · filed 2017-05-09 |
| 2015-12-31 | $40.37K 10-Q · filed 2017-02-07 | $80.74K 10-Q · filed 2017-02-07 | $121.11K derived: sum of 3 quarters · filed 2017-02-07 | $161.48K derived: sum of 4 quarters · filed 2017-02-07 |
| 2015-09-30 | $40.37K 10-Q/A · filed 2017-01-19 | $80.74K derived: sum of 2 quarters · filed 2017-01-19 | $121.11K derived: sum of 3 quarters · filed 2017-01-19 | $161.48K derived: sum of 4 quarters · filed 2017-01-19 |
| 2015-06-30 | $40.37K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $80.74K derived: sum of 2 quarters · filed 2016-09-28 | $121.11K derived: sum of 3 quarters · filed 2016-09-28 | $161.93K 10-K · filed 2016-09-28 |
| 2015-03-31 | $40.37K 10-Q · filed 2016-05-23 | $80.74K derived: sum of 2 quarters · filed 2016-05-23 | $121.56K 10-Q · filed 2016-05-23 | |
| 2014-12-31 | $40.37K 10-Q · filed 2016-02-16 | $81.19K 10-Q · filed 2016-02-16 | ||
| 2014-09-30 | $40.83K 10-Q · filed 2015-11-13 | |||
| 2014-06-30 | $161.47K 10-K · filed 2015-10-01 | |||
| 2013-12-31 | $28.13K 10-Q · filed 2015-02-05 | $70.86K 10-Q · filed 2015-02-05 | ||
| 2013-09-30 | $42.16K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |